288 related articles for article (PubMed ID: 20108649)
1. Hydrophilic nasal gel of lidocaine hydrochloride. 2nd communication: Improved bioavailability and brain delivery in rats with low ciliotoxicity.
Hu KL; Mei N; Feng L; Jiang XG
Arzneimittelforschung; 2009; 59(12):635-40. PubMed ID: 20108649
[TBL] [Abstract][Full Text] [Related]
2. Hydrophilic nasal gel of lidocaine hydrochloride. 1st Communication: Preparation, formulation optimization and in vitro release study.
Hu KL; Mei N; Feng L; Jiang XG
Arzneimittelforschung; 2009; 59(11):543-9. PubMed ID: 20066962
[TBL] [Abstract][Full Text] [Related]
3. Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats.
Khan S; Patil K; Bobade N; Yeole P; Gaikwad R
J Drug Target; 2010 Apr; 18(3):223-34. PubMed ID: 20030503
[TBL] [Abstract][Full Text] [Related]
4. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties.
Zaki NM; Awad GA; Mortada ND; Abd Elhady SS
Eur J Pharm Sci; 2007 Dec; 32(4-5):296-307. PubMed ID: 17920822
[TBL] [Abstract][Full Text] [Related]
5. A microdialysis model to examine nasal drug delivery and olfactory absorption in rats using lidocaine hydrochloride as a model drug.
Bagger M; Bechgaard E
Int J Pharm; 2004 Jan; 269(2):311-22. PubMed ID: 14706243
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid bioavailability and pharmacokinetics of bupivacaine and lidocaine after intrathecal and epidural administrations in rabbits using microdialysis.
Clement R; Malinovsky JM; Le Corre P; Dollo G; Chevanne F; Le Verge R
J Pharmacol Exp Ther; 1999 May; 289(2):1015-21. PubMed ID: 10215682
[TBL] [Abstract][Full Text] [Related]
7. Development, characterization and application of in situ gel systems for intranasal delivery of tacrine.
Qian S; Wong YC; Zuo Z
Int J Pharm; 2014 Jul; 468(1-2):272-82. PubMed ID: 24709220
[TBL] [Abstract][Full Text] [Related]
8. Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats.
Khan S; Patil K; Yeole P; Gaikwad R
J Pharm Pharmacol; 2009 May; 61(5):669-75. PubMed ID: 19406007
[TBL] [Abstract][Full Text] [Related]
9. Development of in situ gel for nasal delivery: design, optimization, in vitro and in vivo evaluation.
Galgatte UC; Kumbhar AB; Chaudhari PD
Drug Deliv; 2014 Feb; 21(1):62-73. PubMed ID: 24191774
[TBL] [Abstract][Full Text] [Related]
10. Rapid-onset intranasal delivery of metoclopramide hydrochloride Part II: Safety of various absorption enhancers and pharmacokinetic evaluation.
Zaki NM; Mortada ND; Awad GA; Abd ElHady SS
Int J Pharm; 2006 Dec; 327(1-2):97-103. PubMed ID: 16959453
[TBL] [Abstract][Full Text] [Related]
11. Preparation of bisoprolol fumarate nasal spray and its nasal delivery in rats.
Fugen G; Duo H; Gendalai M; Chunzhi W; Yi W
Pak J Pharm Sci; 2015 Nov; 28(6):2173-8. PubMed ID: 26639509
[TBL] [Abstract][Full Text] [Related]
12. Drug brain distribution following intranasal administration of Huperzine A in situ gel in rats.
Zhao Y; Yue P; Tao T; Chen QH
Acta Pharmacol Sin; 2007 Feb; 28(2):273-8. PubMed ID: 17241531
[TBL] [Abstract][Full Text] [Related]
13. Nasal administration of metoclopramide from different dosage forms: in vitro, ex vivo, and in vivo evaluation.
Tas C; Ozkan CK; Savaser A; Ozkan Y; Tasdemir U; Altunay H
Drug Deliv; 2009 Apr; 16(3):167-75. PubMed ID: 19514977
[TBL] [Abstract][Full Text] [Related]
14. Preparation of ergoloid mesylate submicron emulsions for enhancing nasal absorption and reducing nasal ciliotoxicity.
Yu C; Meng J; Chen J; Tang X
Int J Pharm; 2009 Jun; 375(1-2):16-21. PubMed ID: 19504748
[TBL] [Abstract][Full Text] [Related]
15. Carbamazepine uptake into rat brain following intra-olfactory transport.
Barakat NS; Omar SA; Ahmed AA
J Pharm Pharmacol; 2006 Jan; 58(1):63-72. PubMed ID: 16393465
[TBL] [Abstract][Full Text] [Related]
16. Modulation of brain delivery and copulation by intranasal apomorphine hydrochloride.
Lu W; Jiang W; Chen J; Yin M; Wang Z; Jiang X
Int J Pharm; 2008 Feb; 349(1-2):196-205. PubMed ID: 17904315
[TBL] [Abstract][Full Text] [Related]
17. Permeation-enhancing effects of chitosan formulations on recombinant hirudin-2 by nasal delivery in vitro and in vivo.
Zhang YJ; Ma CH; Lu WL; Zhang X; Wang XL; Sun JN; Zhang Q
Acta Pharmacol Sin; 2005 Nov; 26(11):1402-8. PubMed ID: 16225765
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability of Δ⁹-tetrahydrocannabinol following intranasal administration of a mucoadhesive gel spray delivery system in conscious rabbits.
Al-Ghananeem AM; Malkawi AH; Crooks PA
Drug Dev Ind Pharm; 2011 Mar; 37(3):329-34. PubMed ID: 21244195
[TBL] [Abstract][Full Text] [Related]
19. Brain targeting and toxicity study of odorranalectin-conjugated nanoparticles following intranasal administration.
Wen Z; Yan Z; He R; Pang Z; Guo L; Qian Y; Jiang X; Fang L
Drug Deliv; 2011 Nov; 18(8):555-61. PubMed ID: 21812752
[TBL] [Abstract][Full Text] [Related]
20. Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting.
Wang X; Chi N; Tang X
Eur J Pharm Biopharm; 2008 Nov; 70(3):735-40. PubMed ID: 18684400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
